ctrl K

Watchlist Price Alert

OS Therapies (OSTX)

NYSE: OSTX · Real-Time Price · USD

2.33

0.13 (5.91%)

At close: May 06, 2025, 3:59 PM

2.33

0.22%

Pre-market: May 07, 2025, 07:01 AM EDT

OS Therapies Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	4.25K
Gross Profit	n/a	n/a	n/a	n/a	-4.25K
Operating Income	-6.81B	-4.34M	-4.45M	-4.84M	-5.65K
Interest Income	n/a	2.00	n/a	n/a	n/a
Pretax Income	-8.88B	-7.79M	-6.25M	-7.42M	-6.03K
Net Income	-8.88B	-7.79M	-6.25M	-7.42M	-6.03K
Selling & General & Admin	3.97B	1.12M	1.15M	1.5M	795.42
Research & Development	2.84B	3.22M	3.29M	2.17M	601.78
Other Expenses	n/a	5.15K	1.21K	1.16M	n/a
Operating Expenses	6.81M	4.34M	4.45M	4.84M	1.4K
Interest Expense	n/a	3.45M	1.81M	2.58M	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	4.34M	4.45M	4.84M	5.65K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	123.77M	20.05M	23.1M	23.1M	8.42M
Shares Outstanding (Diluted)	123.77M	20.05M	23.1M	23.1M	8.42M
EPS (Basic)	-71.77	-0.39	-0.28	-0.33	-0.00
EPS (Diluted)	-71.77	-0.39	-0.28	-0.33	-0.00
EBITDA	-6.81B	-4.34M	-4.45M	-4.84M	-5.65K
EBIT	-10.93B	-4.34M	-4.45M	-4.84M	-5.65K
Depreciation & Amortization	4.12B	4.22K	805.00	805.00	0.07